We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Endo, Impax Face Another Pay-for-Delay Lawsuit Over Generic Opana ER
Endo, Impax Face Another Pay-for-Delay Lawsuit Over Generic Opana ER
Brandmaker Endo Pharmaceuticals and generics firm Impax Laboratories are facing their third lawsuit over allegations the companies cut an anticompetitive deal to delay generic competition on Endo’s pain medication Opana ER.